Press releaseGlobe Newswire
CERo Therapeutics Holdings
CERO · NASDAQ
$0.0052−$0.0009 (−14.75%)TodayMarket closed ·
Prev close $0.0061
Latest news
- Press releaseGlobe Newswire
CERo Therapeutics to Present Late-Breaking Oral Poster Session Highlighting Interim Phase 1 Data from CERTAIN-T Trial Highlighting Platelet Transfusion Independence in a High-Risk MDS/AML Patient
- Press releaseGlobe Newswire
CERo Therapeutics Provides Clinical Update on Phase 1 Trial of CER-1236 in AML (CertainT-1) Highlighting Key Safety Data and Platelet Transfusion–Free Interval Observed in a Patient with Myelodysplastic Syndrome/AML
- News
12 Health Care Stocks Moving In Thursday's Intraday Session
- NewsAvi Kapoor
Nasdaq Falls Over 1%; Alphabet Posts Upbeat Earnings
- News
12 Health Care Stocks Moving In Thursday's Pre-Market Session
- NewsAvi Kapoor
Why Alphabet Shares Are Trading Higher By Around 8%; Here Are 20 Stocks Moving Premarket
- News
CERo Therapeutics Authorizes Investigators Under Study Protocol To Administer Third Infusion Of CER-1236 To Patient Enrolled In First Cohort Of Ongoing Phase 1 Clinical Trial
- Press releaseGlobe Newswire
CERo Therapeutics Announces Third Dose for Patient in Phase 1 Clinical Trial of CER-1236 in AML
- Press releaseGlobe Newswire
CERo Therapeutics to Participate in Stem Cell Therapy Panel at the Maxim Growth Summit 2025
- Press releaseGlobe Newswire
CERo Therapeutics Announces Completion of First Cohort of Phase 1 Clinical Trial of CER-1236 in AML
- Press releaseGlobe Newswire
CERo Therapeutics Receives Notice of Allowance from U.S. Patent and Trade Office on Composition of Matter and Method of Use for CER-1236 in Cancer with Expected Protection Through 2041
- News
12 Health Care Stocks Moving In Friday's Pre-Market Session
- Press releaseGlobe Newswire
CERo Therapeutics Receives FDA Fast Track Designation for CER-1236 in Acute Myeloid Leukemia (AML)
- NewsAvi Kapoor
Why Docusign Shares Are Trading Higher By Over 8%; Here Are 20 Stocks Moving Premarket
- News
12 Health Care Stocks Moving In Wednesday's Intraday Session
- NewsAvi Kapoor
Dow Surges 150 Points; Korn Ferry Earnings Top Views
- News
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
- NewsRishabh Mishra
US Stocks Likely To Open Higher Despite Trump's 'Unconditional Surrender' Call: All Eyes On Powell As Experts Predict Inflation Will Limit Fed's Rate Cut Capacity
- NewsAvi Kapoor
Dow Dips Around 300 Points As Israel-Iran Conflict Escalates: Investor Sentiment Declines, Fear & Greed Index Moves To 'Neutral' Zone
- NewsAvi Kapoor
Crude Oil Rises Sharply; Jabil Earnings Top Views
- NewsAvi Kapoor
US Stocks Lower; Retail Sales Decline In May
- News
Market-Moving News for June 17th
- NewsRishabh Mishra
US Stocks Likely To Open On A Mixed Note After S&P 500 Scales 6,000-Mark: 'Whole Globe Is In A Bull Market'
- NewsAvi Kapoor
Gold Gains 1%; Bristol Myers Squibb Posts Upbeat Results
- NewsAvi Kapoor
Dow Jumps Over 200 Points; PepsiCo Cuts Earnings Outlook
- News
12 Health Care Stocks Moving In Thursday's Intraday Session
- News
12 Health Care Stocks Moving In Friday's Pre-Market Session
- NewsAvi Kapoor
Nasdaq Tumbles Over 200 Points; Alibaba Posts Upbeat Sales
- News
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
- News
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
- News
12 Health Care Stocks Moving In Monday's Pre-Market Session
- NewsAvi Kapoor
Crude Oil Down 3%; Aramark Posts Upbeat Earnings
- NewsAvi Kapoor
Nasdaq Moves Lower; Canaan Shares Surge
- NewsAvi Kapoor
Dow Jumps Over 400 Points; Monday.com Shares Fall After Q3 Results
- NewsAvi Kapoor
Dow Tumbles Over 200 Points; CERo Therapeutics Shares Jump
- NewsAvi Kapoor
Crude Oil Down Over 1%; Stitch Fix Shares Plummet
- NewsAvi Kapoor
Why Granite Point Mortgage Trust Shares Are Trading Higher; Here Are 20 Stocks Moving Premarket
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.